Echocardiography detecting many more cases of definite and borderline rheumatic heart disease

September 27, 2013

How using echocardiography is increasing detection rates of rheumatic heart disease (RHD) many-fold is the subject of one of the papers in the RHD special issue of Global Heart, the journal of the World Heart Federation, and written by Dr Anita Saxena, All India Institute of Medical Sciences, New Delhi, India; Dr Liesl Zühlke, University of Cape Town and Red Cross War Memorial Children's Hospital, Cape Town, South Africa; and Dr Nigel Wilson, Starship Hospital, Auckland, New Zealand.

In 2012, the World Heart Federation introduced new guidelines for diagnosis of RHD using , providing clear definitions that raised the bar for definite cases of RHD, and also borderline cases of RHD (that were showing echocardiographic abnormalities but as yet no clinical symptoms of disease), as compared with the previous WHO criteria issued in 2004.

The paper presents data from New Zealand, India, and Africa, all showing that using echocardiography increases detection rates of both definite RHD cases and borderline cases (abnormal without clinical symptoms).

In New Zealand, the WHF Criteria found a 10 per 1000 definite RHD case rate in schoolchildren aged 10-13 years, and a 24 per 1000 borderline rate. Echocardiographic screening has been used in New Zealand since 2008.

In India, in a study of 6270 children aged 5-15 years, using WHO criteria, 20 cases per 1000 (including definite and borderline cases) were detected using echocardiography, compared with clinical detection rates of just 1 case per 1000. Being older or female almost doubled the risk of RHD, and being in a government funded school rather than private (a measure of poverty) increased risk by 55%. Similar increased detection rates with echocardiography were found in Africa, with one study in Mozambique examining 2,170 children mean age 11 years finding a prevalence of echocardiographic RHD was 30.4 per 1,000 children compared with 2.3 per 1,000 diagnosed clinically.

The authors discuss the problems, both ethically and financially, with how to deal with borderline cases in terms of secondary prophylaxis, as there is not enough information on the natural course of the disease to assess whether beginning secondary prophylaxis with benzathine penicillin G (BPG) injections will prevent . At the moment, in India and New Zealand, borderline cases are not being given BPG, but are instead undergoing active surveillance to check for signs of disease progression. A prospective, international, multicenter registry of definite and borderline RHD (known as the DefineRHD registry) is being implemented. Follow-up of secondary penicillin status with frequent reporting (3-monthly) and echocardiography changes (2-yearly) should answer the question whether those with definite RHD receiving good secondary prophylaxis will show less disease progression and more disease regression than will those with no or poor secondary prophylaxis.

And, as the authors point out, "The acceptability of long-term secondary prophylaxis for those with echocardiographically detected RHD has not been established or researched. In most regions, children with an episode of acute rheumatic fever are admitted to hospital with the acute illness, often with painful arthritis. This allows families to understand well and accept, usually, the importance of secondary prophylaxis. In contrast, the logic for secondary prophylaxis may not be understood by the family of an otherwise healthy child who is found to have echocardiographic RHD."

The authors conclude: "Portable echocardiography is a relatively new screening tool for RHD, which has raised awareness of the high prevalence of RHD in many countries...The natural history of subclinical echocardiographically detected RHD is the most important research question to be answered before more widespread screening is endorsed."

Explore further: First international guidelines for echocardiographic diagnosis of rheumatic heart disease

Related Stories

First international guidelines for echocardiographic diagnosis of rheumatic heart disease

February 28, 2012
The inaugural international guidelines for the diagnosis of rheumatic heart disease (RHD), a disease that affects tens of millions of people worldwide, have today been published by the World Heart Federation in Nature Reviews ...

Rheumatic heart disease: A new era of pushing for global control as World Heart Day approaches

September 26, 2013
As this year's World Heart Day approaches (Sunday September 29), focus is returning to a neglected and entirely preventable heart disease that largely affects the world's youngest and poorest populations: rheumatic heart ...

Increasing awareness that untreated sore throat can lead to rheumatic heart disease is a huge part of the battle

September 27, 2013
Without a huge improvement in living conditions, a cure, or a vaccine, rheumatic heart disease (RHD) will continue to blight low-income and middle-income countries. Raising community awareness of the condition, emphasising ...

Diagnosing, treating sore throat (primary prevention) should be part of strategy to prevent rheumatic heart disease

September 26, 2013
Diagnosing and treating sore (strep) throat (primary prevention) in children and adolescents to prevent such cases developing into acute rheumatic fever (ARF) and rheumatic heart disease (RHD) should be a cornerstone in any ...

How can supply of penicillin be an issue in any country in 2013?

September 26, 2013
Benzathine penicillin G (BPG) is the most essential antibiotic for the treatment and prevention of group A streptococcal infections associated with rheumatic fever and rheumatic heart disease. Yet while some countries such ...

Screening programs detect cases of undiagnosed rheumatic heart disease in low-resource countries

April 21, 2012
Widespread screening of children in poorer countries is now being studied and is resulting in the diagnosis of rheumatic heart disease (RHD) in patients that would likely have gone undetected under normal circumstances, according ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.